Thermo Fisher [TMO] vs Natera [NTRA] Detailed Stock Comparison

Thermo Fisher Scientific Inc.

NYSE
Loading...

Natera Inc.

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Thermo Fisher Scientific Inc. wins in 15 metrics, Natera Inc. wins in 2 metrics, with 0 ties. Thermo Fisher Scientific Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Thermo Fisher Scientific Inc. Natera Inc. Better
P/E Ratio (TTM) 25.84 N/A N/A
Price-to-Book Ratio 3.31 15.75 Thermo Fisher Scientific Inc.
Debt-to-Equity Ratio 82.91 12.52 Natera Inc.
PEG Ratio 2.29 -272.56 Thermo Fisher Scientific Inc.
EV/EBITDA 19.02 -97.62 Thermo Fisher Scientific Inc.
Profit Margin (TTM) 15.15% -9.03% Thermo Fisher Scientific Inc.
Operating Margin (TTM) 17.89% -3.42% Thermo Fisher Scientific Inc.
EBITDA Margin (TTM) 17.89% N/A N/A
Return on Equity 13.52% -14.32% Thermo Fisher Scientific Inc.
Return on Assets (TTM) 5.00% -9.54% Thermo Fisher Scientific Inc.
Free Cash Flow (TTM) $6.29B $76.11M Thermo Fisher Scientific Inc.
Dividend Yield 0.38% N/A N/A
1-Year Return 16.53% 28.26% Natera Inc.
Price-to-Sales Ratio (TTM) 3.86 11.86 Thermo Fisher Scientific Inc.
Enterprise Value $214.76B $26.50B Thermo Fisher Scientific Inc.
EV/Revenue Ratio 4.75 11.49 Thermo Fisher Scientific Inc.
Gross Profit Margin (TTM) N/A 66.93% N/A
Revenue per Share (TTM) $120 $17 Thermo Fisher Scientific Inc.
Earnings per Share (Diluted) $18.18 $-1.52 Thermo Fisher Scientific Inc.
Beta (Stock Volatility) 0.97 1.68 Thermo Fisher Scientific Inc.
Short % of Float 1.22% 2.43% Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc. vs Natera Inc. Stock Performance Analysis

Loading Price Chart...

TMO
NTRA

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Thermo Fisher Scientific Inc.0.93%0.87%8.07%0.79%-17.74%-20.05%
Natera Inc.0.51%-1.50%3.85%11.43%-8.57%-7.33%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Thermo Fisher Scientific Inc.16.53%-12.65%-2.72%220.94%654.32%1,231.84%
Natera Inc.28.26%322.03%106.13%1,750.52%1,078.17%1,078.17%

Performance & Financial Health Analysis: Thermo Fisher Scientific Inc. vs Natera Inc.

MetricTMONTRA
Market Information
Market Cap i$174.55B$27.36B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i2,356,2201,322,470
90 Day Avg. Volume i2,071,5171,333,993
Last Close$473.72$171.86
52 Week Range$385.46 - $643.99$92.14 - $183.00
% from 52W High-26.44%-6.09%
All-Time High$672.34 (Dec 27, 2021)$183.00 (Jan 13, 2025)
% from All-Time High-29.54%-6.09%
Growth Metrics
Quarterly Revenue Growth0.06%0.40%
Quarterly Earnings Growth0.10%N/A
Financial Health
Profit Margin (TTM) i0.15%-0.09%
Operating Margin (TTM) i0.18%-0.03%
Return on Equity (TTM) i0.14%-0.14%
Debt to Equity (MRQ) i82.9112.52
Cash & Liquidity
Book Value per Share (MRQ)$141.96$12.26
Cash per Share (MRQ)$8.75$7.59
Operating Cash Flow (TTM) i$8.29B$215.30M
Levered Free Cash Flow (TTM) i$5.51B$141.02M
Dividends
Last 12-Month Dividend Yield i0.38%N/A
Last 12-Month Dividend i$1.76N/A

Valuation & Enterprise Metrics Analysis: Thermo Fisher Scientific Inc. vs Natera Inc.

MetricTMO (Apr 26, 2026)NTRA (Apr 13, 2026)
Price Ratios
P/E Ratio (TTM) i25.84N/A
Forward P/E i17.16-272.56
PEG Ratio i2.29-272.56
Price to Sales (TTM) i3.8611.86
Price to Book (MRQ) i3.3115.75
Market Capitalization
Market Capitalization i$174.55B$27.36B
Enterprise Value i$214.76B$26.50B
Enterprise Value Metrics
Enterprise to Revenue i4.7511.49
Enterprise to EBITDA i19.02-97.62
Risk & Other Metrics
Beta i0.971.68
Book Value per Share (MRQ) i$141.96$12.26

Financial Statements Comparison: Thermo Fisher Scientific Inc. vs Natera Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricTMO (2025)NTRA (2025)
Revenue/Sales i44.56B2.31B
Cost of Goods Sold i26.32B812.93M
COGS % of Revenue i59.1%35.3%
Gross Profit i18.24B1.49B
Gross Margin i40.9%64.7%
Research & Development i1.40B624.11M
Operating Income (EBIT) i8.11B-309.91M
Operating Margin i18.2%-13.4%
EBITDA i11.86B-220.54M
EBITDA Margin i26.6%-9.6%
Pre-Tax Income i7.31B-268.09M
Pre-Tax Income % of Revenue i16.4%-11.6%
Income Tax i547.00M-59.93M
Income Tax % of Revenue i1.2%-2.6%
Net Income (Profit) i6.72B-208.16M
Profit Margin i15.1%-9.0%

Balance Sheet & Liquidity Metrics

MetricTMO (2025)NTRA (2025)
Cash & Equivalents i9.85B1.08B
Total Current Assets i28.71B1.50B
Total Current Assets % of Revenue i64.4%64.9%
Total Current Liabilities i15.19B441.23M
Total Current Liabilities % of Revenue i34.1%19.1%
Long-Term Debt i35.85B118.47M
Long-Term Debt % of Revenue i80.5%5.1%
Total Shareholders Equity i53.54B1.71B
Retained Earnings i59.16B-2.78B
Retained Earnings % of Revenue i132.8%-120.4%
Property, Plant & Equipment i0108.54M

Cash Flow Statement Comparison

MetricTMO (2025)NTRA (2025)
Operating Cash Flow i7.82B135.51M
Operating Cash Flow % of Revenue i17.5%5.9%
Capital Expenditures i-1.48B-106.19M
Free Cash Flow i6.29B76.11M
FCF Margin i14.1%3.3%
Debt Repayment i-3.51B0
Common Stock Repurchase i-3.00BN/A

Short Interest & Institutional Ownership Analysis

MetricTMONTRA
Shares Short i4.54M3.31M
Short Ratio i2.382.76
Short % of Float i1.22%2.43%
Shares Outstanding i371.62M139.69M
Float Shares i371.07M137.44M
% Held by Insiders i0.17%3.07%
% Held by Institutions i95.23%94.58%
% Held by Public i4.60%2.35%

Dividend Analysis & Yield Comparison: Thermo Fisher Scientific Inc. vs Natera Inc.

MetricTMONTRA
Last 12-Month Dividend i$1.76N/A
Last 12-Month Dividend Yield i0.38%N/A
3-Year Avg Annual Dividend i$1.60N/A
3-Year Avg Dividend Yield i0.08%N/A
3-Year Total Dividends i$4.80N/A
Ex-Dividend DateMar 13, 2026N/A